KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
10+ emerging markets, Japan & ANZ transition in final phase
Expands patient reach to remotest towns by furthering investment in GoApptiv
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Leading USA based genetic testing brand officially enters the Indian market
Dr. Reddy's Laboratories has been issued a Form 483 with three observations
his marks the 12th formulation facility under Akums, and the second in Baddi, a strategic move with an aim to enhance Akums’ manufacturing capabilities.
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
Subscribe To Our Newsletter & Stay Updated
